Zonisamide-13C6
Zonisamide-13C6
SKU:QM-0017969
Request quote or documents
Product Details
-
Description
Zonisamide-13C6 (AD 810-13C6) is 13C labeled Zonisamide. Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy[1][2][3][4].
-
Molecular Formula
C2 13C6H4N2O3S
-
Molecular Weight
214.15
-
Smiles
O=S(N)(CC1=NO[13C]2=[13C]1[13C]=[13C][13C]=[13C]2)=O
-
Target
Apoptosis; Carbonic Anhydrase; Isotope-Labeled Compounds
-
Shipping Conditions
Room temperature
Related Products
- QM-0016783 β-Hydroxydecanoyl-CoA [CAS 6245-70-1]
- QM-0008296 Z-VAD-FMK (GMP) [CAS 161401-82-7]
- QM-0007385 β-galactosidase mRNA (N1-Methylpseudo-UTP)
- QM-0007254 α-Pseudouridine [CAS 10017-66-0]
- QM-0206006 β-Nicotinamide adenine dinucleotide reduced (dipotassium) [CAS 104809-32-7]
- QM-0150801-01 Zidesamtinib [CAS 2739829-00-4]
- QM-0150376-01 Zonampanel [CAS 210245-80-0]
- QM-0204726-01 β-Nicotinamide mononucleotide, reduced form (disodium) [CAS 108347-85-9]
- QM-0157520-01 Zonisamide (Standard) [CAS 68291-97-4]
- QM-0150536-01 XAV-939 (GMP) [CAS 284028-89-3]
Other industry favorites
- QM-0016783 β-Hydroxydecanoyl-CoA [CAS 6245-70-1]
- QM-0008296 Z-VAD-FMK (GMP) [CAS 161401-82-7]
- QM-0178574-01 β-Sitosterol acetate, 40% (contains Campesterol acetate) [CAS 915-05-9]
- QM-0173666 β-N-Acetylhexosaminidase, Porcine kidney [CAS 9012-33-3]
- QM-0019907 Zanamivir-CoA
- QM-0019906 Z-Dehydrobutyrine-CoA
Zonisamide-13C6
Zonisamide-13C6 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.